Milrinone
Back to searchMolecule Structure
Scientific Name
Milrinone
Description of the Drug
Milrinone is a PDE-III inhibitor with inotropic, lusitropic, and vasodilatory properties used for the short-term treatment of acute decompensated heart failure.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00235
http://www.drugbank.ca/drugs/DB00235
Brand Name(s)
Primacor
Company Owner(s)
Woodward Pharma Services Llc, Fresenius Kabi Usa Llc, West-Ward Pharmaceuticals International Ltd, Hospira Inc, Hikma Farmaceutica (Portugal) Sa, Caplin Steriles Ltd, Gland Pharma Ltd, Hikma Pharmaceuticals Usa Inc, Eugia Pharma Specialities Ltd, B Braun Medical Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Phosphodiesterase 3A | SINGLE PROTEIN | INHIBITOR | CHEMBL241 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL36947 | |
| PharmGKB | PA164749171 | |
| Human Metabolome Database | HMDB0014380 | |
| DrugBank | DB00235 | |
| PubChem: Thomson Pharma | 14773322 | 14797712 |
| PubChem | 4197 | |
| Mcule | MCULE-8377851655 | |
| LINCS | LSM-3493 | |
| Nikkaji | J23.655A | |
| PDBe | MIL | |
| BindingDB | 15296 | |
| EPA CompTox Dashboard | DTXSID5023324 | |
| DrugCentral | 1809 | |
| Brenda | 3352 | |
| Guide to Pharmacology | 5225 | |
| rxnorm | MILRINONE LACTATE | MILRINONE |
| PubChem: Drugs of the Future | 12013065 | |
| KEGG Ligand | C07224 | |
| ChEBI | 50693 | |
| ZINC | ZINC000009224016 |
